According to @business, Bloomberg reports that Foundation Healthcare, backed by Singapore investment firm Temasek, is considering an IPO that could value the medical group at more than $1 billion, per Bloomberg. Traders should note that Bloomberg’s reported $1B-plus valuation implies a potentially sizable float and liquidity event if the deal proceeds, which can influence pricing and allocations across regional healthcare new listings, according to Bloomberg.

According to @business, MapLight Therapeutics has filed for an IPO, making it one of the few biotechnology listings moving forward in a tough year for the sector (source: Bloomberg post dated Sep 19, 2025). The source highlights a weak 2025 biotech IPO pipeline and does not indicate any direct cryptocurrency market impact (source: @business).

According to @business, Polish children’s toys and apparel retailer Smyk has hired banks to run an initial public offering that could kick off as soon as this month, indicating a near-term Warsaw listing timeline (source: Bloomberg/@business tweet and linked report, Sep 19, 2025). Based on the Bloomberg/@business report, traders should monitor pre-IPO headline risk and potential sympathy moves in Warsaw Stock Exchange consumer discretionary peers as deal milestones approach, while noting that the source did not disclose offering size, valuation, or bookrunners, which limits immediate pricing models and comps analysis (source: Bloomberg/@business). For crypto markets, the source provides no direct linkage; any impact is limited to broader European risk sentiment rather than specific drivers for BTC or ETH (source: Bloomberg/@business).